Hansoh Pharmaceutical Group Company Ltd

Return on Assets, %

10.2

-2.7

Net income margin, %

35.5

2.8

EBITDA margin, %

45

10.8

Debt to Equity, %

16.6

19.2

Intangible assets and goodwill, %

0.5

3.6

Revenue CAGR 3Y, %

5.1

8.5

Revenue Y, % chg

2.2

0.5

P/E

27.3

22.7

P/BV

3.4

1.5

P/S

8.7

2.3

EV/S

6.6

2.4

EV/EBITDA

18.5

7.4

Average Analyst recommendation

Buy

Buy

Average upside forecasts, %

11.5

51.3

Forward P/E

24

15.6

Dividend Yield, %

1.3

1.7

Forward Dividend Yield, %

0.1

0.2

Expected dividend per share

0

0

Payout Ratio, %

19.7

30.3

Dividend Ex Date

2024-06-19